Fig. 2From: Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N’Djamena, Chad: findings from a cross-sectional studyPrevalence of NRTI DRMs. NRTI nucleoside reverse transcriptase inhibitors, RT reverse transcriptase, DRMs drug resistant mutationsBack to article page